• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Announcements

8.82% ! 15.5¢
Market Cap $35.02M  !

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Announcements



CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/21 download Created with Sketch. 496.46KB
CYP Cynata Receives US$5m Fujifilm FeePRICE SENSITIVE18/10/21 download Created with Sketch. 219.76KB
CYP Annual Report to shareholders14/10/21 download Created with Sketch. 11.61MB
CYP Letter to Shareholders & Notice of Annual General Meeting14/10/21 download Created with Sketch. 1.07MB
CYP Notification regarding unquoted securities - CYP12/10/21 download Created with Sketch. 27.91KB
CYP DSMB Recommends Continuation of Cynata's MEND TrialPRICE SENSITIVE08/10/21 download Created with Sketch. 259.53KB
CYP Cynata Enters into a New Strategic Partnership with FujifilmPRICE SENSITIVE30/09/21 download Created with Sketch. 276.88KB
CYP CYP Preclinical Heart Attack Study Published in Cytotherapy28/09/21 download Created with Sketch. 262.51KB
CYP Date of AGM and Closing Date for Director Nominations21/09/21 download Created with Sketch. 219.02KB
CYP Further Patents for Cynata Unique Cymerus TechnologyPRICE SENSITIVE15/09/21 download Created with Sketch. 251.78KB
CYP Further Canadian Patent for CynataPRICE SENSITIVE31/08/21 download Created with Sketch. 250.76KB
CYP Appendix 4G30/08/21 download Created with Sketch. 285.87KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE30/08/21 download Created with Sketch. 11.79MB
CYP Cynata Receives Notice of Allowance from US Patent OfficePRICE SENSITIVE26/08/21 download Created with Sketch. 194.84KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/21 download Created with Sketch. 363.27KB
CYP Cynata Appoints Dr Jolanta Airey Chief Medical Officer26/07/21 download Created with Sketch. 202.54KB
CYP Change of Registered Office05/07/21 download Created with Sketch. 160.36KB
CYP Ethics Approval for Cynata's Clinical Trial in DFUPRICE SENSITIVE30/06/21 download Created with Sketch. 622.16KB
CYP Progress Toward Clinical Trial in Diabetic Foot UlcersPRICE SENSITIVE28/06/21 download Created with Sketch. 165.1KB
CYP Cynata to Present at MST Access Investor Conference 15 June11/06/21 download Created with Sketch. 181.59KB
CYP Cynata signs Licence Agreement with TekCytePRICE SENSITIVE03/06/21 download Created with Sketch. 202.54KB
CYP Release of Securities from Voluntary Escrow28/05/21 download Created with Sketch. 161.01KB
CYP First Patient Enrolled in Cynata MEND Clinical TrialPRICE SENSITIVE24/05/21 download Created with Sketch. 207.31KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/04/21 download Created with Sketch. 331.3KB
CYP Cynata Expands trial in COVID-19 & Respiratory FailurePRICE SENSITIVE29/03/21 download Created with Sketch. 1.75MB
CYP Cynata Investor Presentation12/03/21 download Created with Sketch. 1.34MB
CYP New Study to Investigate the High Potency of Cymerus MSCs02/03/21 download Created with Sketch. 192.34KB
CYP Cynata Advances Planned Clinical Trial in DFU with TekCyte01/03/21 download Created with Sketch. 199.39KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/21 download Created with Sketch. 767.33KB
CYP Cynata Receives $1.39m R&D Tax Incentive RefundPRICE SENSITIVE22/02/21 download Created with Sketch. 162.94KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/01/21 download Created with Sketch. 300.45KB
CYP Cleansing Notice20/01/21 download Created with Sketch. 187.87KB
CYP Appendix 2A20/01/21 download Created with Sketch. 166.86KB
CYP Completion of Entitlement Offer and Shortfall PlacementPRICE SENSITIVE18/01/21 download Created with Sketch. 204.04KB
CYP Entitlement Offer Closing Date Reminder11/01/21 download Created with Sketch. 165.34KB
CYP Cleansing Notice31/12/20 download Created with Sketch. 187.19KB
CYP Appendix 2A30/12/20 download Created with Sketch. 160.89KB
CYP 2020 Review and Outlook30/12/20 download Created with Sketch. 208.95KB
CYP Becoming a substantial holder29/12/20 download Created with Sketch. 665.22KB
CYP Cleansing Notice24/12/20 download Created with Sketch. 187.31KB
CYP Appendix 2A23/12/20 download Created with Sketch. 167.17KB
CYP Letter to Ineligible Shareholders21/12/20 download Created with Sketch. 266.97KB
CYP Offer Booklet and Entitlement & Acceptance FormPRICE SENSITIVE21/12/20 download Created with Sketch. 11.91MB
CYP Cynata Entitlement Offer Opens21/12/20 download Created with Sketch. 201KB
CYP Cleansing Notice21/12/20 download Created with Sketch. 187.34KB
CYP Cynata provides update on Placement and Appendix 2A18/12/20 download Created with Sketch. 397.77KB
CYP Letter to Optionholders15/12/20 download Created with Sketch. 229.95KB
CYP Notice Under Section 708AA of the Corporations Act11/12/20 download Created with Sketch. 248.63KB
CYP Investor PresentationPRICE SENSITIVE11/12/20 download Created with Sketch. 997.27KB
CYP Proposed issue of Securities - CYP11/12/20 download Created with Sketch. 36.44KB
CYP CYP Closes $15m Institutional Placement to Expand PipelinePRICE SENSITIVE11/12/20 download Created with Sketch. 230.55KB
CYP Trading HaltPRICE SENSITIVE09/12/20 download Created with Sketch. 200.58KB
CYP Appendix 3Ys x 530/11/20 download Created with Sketch. 174.75KB
CYP Appendix 3G30/11/20 download Created with Sketch. 134.72KB
CYP Replacement Constitution24/11/20 download Created with Sketch. 645.49KB
CYP Results of Annual General Meeting24/11/20 download Created with Sketch. 187.47KB
CYP AGM Presentations24/11/20 download Created with Sketch. 1.72MB
CYP Cynata Technology Featured on Front Cover of Nature Medicine18/11/20 download Created with Sketch. 204.36KB
CYP Phase 3 Osteoarthritis Clinical Trial CommencesPRICE SENSITIVE11/11/20 download Created with Sketch. 1.7MB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/10/20 download Created with Sketch. 260.25KB
CYP AusBiotech Conference Presentation29/10/20 download Created with Sketch. 1.41MB
CYP Annual Report to Shareholders23/10/20 download Created with Sketch. 14.86MB
CYP Letter to Shareholders, Notice of AGM & Proxy Form23/10/20 download Created with Sketch. 1.02MB
CYP Date of AGM & Closing Date for Director Nominations06/10/20 download Created with Sketch. 162.26KB
CYP Potential Utility of Cymerus MSCs in Heart Attack ModelPRICE SENSITIVE24/09/20 download Created with Sketch. 205.21KB
CYP Cynata Clinical Trial Results Published in Nature Medicine15/09/20 download Created with Sketch. 216.84KB
CYP Appendix 3G14/09/20 download Created with Sketch. 277.77KB
CYP Cymerus MSCs Effective in Preclinical Lung Disease StudyPRICE SENSITIVE07/09/20 download Created with Sketch. 208.88KB
CYP Appendix 4G25/08/20 download Created with Sketch. 222.01KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE25/08/20 download Created with Sketch. 1.98MB
CYP Patient Enrolment Opens in COVID-19 Clinical TrialPRICE SENSITIVE24/08/20 download Created with Sketch. 194.2KB
CYP Appendix 3G19/08/20 download Created with Sketch. 273.62KB
CYP Cynata Appoints Dr Geoff Brooke as ChairmanPRICE SENSITIVE18/08/20 download Created with Sketch. 211.81KB
CYP Cynata Investor Presentation14/08/20 download Created with Sketch. 1.89MB
CYP Notice of Allowance from Korean Patent Office07/08/20 download Created with Sketch. 193.6KB
CYP Notification of Expiry of Unlisted Options05/08/20 download Created with Sketch. 181.77KB
CYP Cynata Announces Positive Results from GvHD Trial Follow-upPRICE SENSITIVE30/07/20 download Created with Sketch. 215.76KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/07/20 download Created with Sketch. 330.6KB
CYP Notification of Expiry of Unlisted Options20/07/20 download Created with Sketch. 181.75KB
CYP Securities Dealing Policy01/07/20 download Created with Sketch. 173.73KB
CYP Final Director's Interest Notice01/07/20 download Created with Sketch. 26.83KB
CYP Appendix 3Y-Dr Geoff Brooke24/06/20 download Created with Sketch. 25.66KB
CYP Ethics Approval & Expedited Pathway for Phase 3 OA TrialPRICE SENSITIVE18/06/20 download Created with Sketch. 211.79KB
CYP Appendix 3X-Darryl Maher16/06/20 download Created with Sketch. 29.64KB
CYP Appendix 3Y-Ross Macdonald16/06/20 download Created with Sketch. 25.53KB
CYP Appendix 3Y-Stewart Washer16/06/20 download Created with Sketch. 25.2KB
CYP Dr Darryl Maher joins Cynata Board16/06/20 download Created with Sketch. 207.69KB
CYP Block Trade Proceeds to Reduce Director LoansPRICE SENSITIVE16/06/20 download Created with Sketch. 202.1KB
CYP Appendix 2A10/06/20 download Created with Sketch. 165.93KB
CYP Investor Presentation10/06/20 download Created with Sketch. 1.71MB
CYP Appendix 2A02/06/20 download Created with Sketch. 166.6KB
CYP Cynata Successfully Completes Share Purchase PlanPRICE SENSITIVE27/05/20 download Created with Sketch. 174.02KB
CYP Ethics Approval to Commence Clinical Trial in COVID-19PRICE SENSITIVE08/05/20 download Created with Sketch. 210.99KB
CYP Cleansing Notice01/05/20 download Created with Sketch. 124.37KB
CYP Appendix 2A01/05/20 download Created with Sketch. 168.11KB
CYP Share Purchase Plan BookletPRICE SENSITIVE30/04/20 download Created with Sketch. 169.42KB
CYP Cleansing Notice24/04/20 download Created with Sketch. 123.75KB
CYP Appendix 2A24/04/20 download Created with Sketch. 168.82KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE24/04/20 download Created with Sketch. 293.28KB
CYP Cynata announces $5.55m capital raisingPRICE SENSITIVE22/04/20 download Created with Sketch. 212.56KB
CYP Quarterly Activity Report & Appendix 4C
28/10/21PRICE SENSITIVE download Created with Sketch. 496.46KB
CYP Cynata Receives US$5m Fujifilm Fee
18/10/21PRICE SENSITIVE download Created with Sketch. 219.76KB
CYP Annual Report to shareholders
14/10/21 download Created with Sketch. 11.61MB
CYP Letter to Shareholders & Notice of Annual General Meeting
14/10/21 download Created with Sketch. 1.07MB
CYP Notification regarding unquoted securities - CYP
12/10/21 download Created with Sketch. 27.91KB
CYP DSMB Recommends Continuation of Cynata's MEND Trial
08/10/21PRICE SENSITIVE download Created with Sketch. 259.53KB
CYP Cynata Enters into a New Strategic Partnership with Fujifilm
30/09/21PRICE SENSITIVE download Created with Sketch. 276.88KB
CYP CYP Preclinical Heart Attack Study Published in Cytotherapy
28/09/21 download Created with Sketch. 262.51KB
CYP Date of AGM and Closing Date for Director Nominations
21/09/21 download Created with Sketch. 219.02KB
CYP Further Patents for Cynata Unique Cymerus Technology
15/09/21PRICE SENSITIVE download Created with Sketch. 251.78KB
CYP Further Canadian Patent for Cynata
31/08/21PRICE SENSITIVE download Created with Sketch. 250.76KB
CYP Appendix 4G
30/08/21 download Created with Sketch. 285.87KB
CYP Appendix 4E & Annual Report
30/08/21PRICE SENSITIVE download Created with Sketch. 11.79MB
CYP Cynata Receives Notice of Allowance from US Patent Office
26/08/21PRICE SENSITIVE download Created with Sketch. 194.84KB
CYP Quarterly Activity Report & Appendix 4C
28/07/21PRICE SENSITIVE download Created with Sketch. 363.27KB
CYP Cynata Appoints Dr Jolanta Airey Chief Medical Officer
26/07/21 download Created with Sketch. 202.54KB
CYP Change of Registered Office
05/07/21 download Created with Sketch. 160.36KB
CYP Ethics Approval for Cynata's Clinical Trial in DFU
30/06/21PRICE SENSITIVE download Created with Sketch. 622.16KB
CYP Progress Toward Clinical Trial in Diabetic Foot Ulcers
28/06/21PRICE SENSITIVE download Created with Sketch. 165.1KB
CYP Cynata to Present at MST Access Investor Conference 15 June
11/06/21 download Created with Sketch. 181.59KB
CYP Cynata signs Licence Agreement with TekCyte
03/06/21PRICE SENSITIVE download Created with Sketch. 202.54KB
CYP Release of Securities from Voluntary Escrow
28/05/21 download Created with Sketch. 161.01KB
CYP First Patient Enrolled in Cynata MEND Clinical Trial
24/05/21PRICE SENSITIVE download Created with Sketch. 207.31KB
CYP Quarterly Activity Report & Appendix 4C
28/04/21PRICE SENSITIVE download Created with Sketch. 331.3KB
CYP Cynata Expands trial in COVID-19 & Respiratory Failure
29/03/21PRICE SENSITIVE download Created with Sketch. 1.75MB
CYP Cynata Investor Presentation
12/03/21 download Created with Sketch. 1.34MB
CYP New Study to Investigate the High Potency of Cymerus MSCs
02/03/21 download Created with Sketch. 192.34KB
CYP Cynata Advances Planned Clinical Trial in DFU with TekCyte
01/03/21 download Created with Sketch. 199.39KB
CYP Appendix 4D & Half-Year Financial Statements
25/02/21PRICE SENSITIVE download Created with Sketch. 767.33KB
CYP Cynata Receives $1.39m R&D Tax Incentive Refund
22/02/21PRICE SENSITIVE download Created with Sketch. 162.94KB
CYP Quarterly Activity Report & Appendix 4C
29/01/21PRICE SENSITIVE download Created with Sketch. 300.45KB
CYP Cleansing Notice
20/01/21 download Created with Sketch. 187.87KB
CYP Appendix 2A
20/01/21 download Created with Sketch. 166.86KB
CYP Completion of Entitlement Offer and Shortfall Placement
18/01/21PRICE SENSITIVE download Created with Sketch. 204.04KB
CYP Entitlement Offer Closing Date Reminder
11/01/21 download Created with Sketch. 165.34KB
CYP Cleansing Notice
31/12/20 download Created with Sketch. 187.19KB
CYP Appendix 2A
30/12/20 download Created with Sketch. 160.89KB
CYP 2020 Review and Outlook
30/12/20 download Created with Sketch. 208.95KB
CYP Becoming a substantial holder
29/12/20 download Created with Sketch. 665.22KB
CYP Cleansing Notice
24/12/20 download Created with Sketch. 187.31KB
CYP Appendix 2A
23/12/20 download Created with Sketch. 167.17KB
CYP Letter to Ineligible Shareholders
21/12/20 download Created with Sketch. 266.97KB
CYP Offer Booklet and Entitlement & Acceptance Form
21/12/20PRICE SENSITIVE download Created with Sketch. 11.91MB
CYP Cynata Entitlement Offer Opens
21/12/20 download Created with Sketch. 201KB
CYP Cleansing Notice
21/12/20 download Created with Sketch. 187.34KB
CYP Cynata provides update on Placement and Appendix 2A
18/12/20 download Created with Sketch. 397.77KB
CYP Letter to Optionholders
15/12/20 download Created with Sketch. 229.95KB
CYP Notice Under Section 708AA of the Corporations Act
11/12/20 download Created with Sketch. 248.63KB
CYP Investor Presentation
11/12/20PRICE SENSITIVE download Created with Sketch. 997.27KB
CYP Proposed issue of Securities - CYP
11/12/20 download Created with Sketch. 36.44KB
CYP CYP Closes $15m Institutional Placement to Expand Pipeline
11/12/20PRICE SENSITIVE download Created with Sketch. 230.55KB
CYP Trading Halt
09/12/20PRICE SENSITIVE download Created with Sketch. 200.58KB
CYP Appendix 3Ys x 5
30/11/20 download Created with Sketch. 174.75KB
CYP Appendix 3G
30/11/20 download Created with Sketch. 134.72KB
CYP Replacement Constitution
24/11/20 download Created with Sketch. 645.49KB
CYP Results of Annual General Meeting
24/11/20 download Created with Sketch. 187.47KB
CYP AGM Presentations
24/11/20 download Created with Sketch. 1.72MB
CYP Cynata Technology Featured on Front Cover of Nature Medicine
18/11/20 download Created with Sketch. 204.36KB
CYP Phase 3 Osteoarthritis Clinical Trial Commences
11/11/20PRICE SENSITIVE download Created with Sketch. 1.7MB
CYP Quarterly Activity Report & Appendix 4C
30/10/20PRICE SENSITIVE download Created with Sketch. 260.25KB
CYP AusBiotech Conference Presentation
29/10/20 download Created with Sketch. 1.41MB
CYP Annual Report to Shareholders
23/10/20 download Created with Sketch. 14.86MB
CYP Letter to Shareholders, Notice of AGM & Proxy Form
23/10/20 download Created with Sketch. 1.02MB
CYP Date of AGM & Closing Date for Director Nominations
06/10/20 download Created with Sketch. 162.26KB
CYP Potential Utility of Cymerus MSCs in Heart Attack Model
24/09/20PRICE SENSITIVE download Created with Sketch. 205.21KB
CYP Cynata Clinical Trial Results Published in Nature Medicine
15/09/20 download Created with Sketch. 216.84KB
CYP Appendix 3G
14/09/20 download Created with Sketch. 277.77KB
CYP Cymerus MSCs Effective in Preclinical Lung Disease Study
07/09/20PRICE SENSITIVE download Created with Sketch. 208.88KB
CYP Appendix 4G
25/08/20 download Created with Sketch. 222.01KB
CYP Appendix 4E & Annual Report
25/08/20PRICE SENSITIVE download Created with Sketch. 1.98MB
CYP Patient Enrolment Opens in COVID-19 Clinical Trial
24/08/20PRICE SENSITIVE download Created with Sketch. 194.2KB
CYP Appendix 3G
19/08/20 download Created with Sketch. 273.62KB
CYP Cynata Appoints Dr Geoff Brooke as Chairman
18/08/20PRICE SENSITIVE download Created with Sketch. 211.81KB
CYP Cynata Investor Presentation
14/08/20 download Created with Sketch. 1.89MB
CYP Notice of Allowance from Korean Patent Office
07/08/20 download Created with Sketch. 193.6KB
CYP Notification of Expiry of Unlisted Options
05/08/20 download Created with Sketch. 181.77KB
CYP Cynata Announces Positive Results from GvHD Trial Follow-up
30/07/20PRICE SENSITIVE download Created with Sketch. 215.76KB
CYP Quarterly Activity Report & Appendix 4C
28/07/20PRICE SENSITIVE download Created with Sketch. 330.6KB
CYP Notification of Expiry of Unlisted Options
20/07/20 download Created with Sketch. 181.75KB
CYP Securities Dealing Policy
01/07/20 download Created with Sketch. 173.73KB
CYP Final Director's Interest Notice
01/07/20 download Created with Sketch. 26.83KB
CYP Appendix 3Y-Dr Geoff Brooke
24/06/20 download Created with Sketch. 25.66KB
CYP Ethics Approval & Expedited Pathway for Phase 3 OA Trial
18/06/20PRICE SENSITIVE download Created with Sketch. 211.79KB
CYP Appendix 3X-Darryl Maher
16/06/20 download Created with Sketch. 29.64KB
CYP Appendix 3Y-Ross Macdonald
16/06/20 download Created with Sketch. 25.53KB
CYP Appendix 3Y-Stewart Washer
16/06/20 download Created with Sketch. 25.2KB
CYP Dr Darryl Maher joins Cynata Board
16/06/20 download Created with Sketch. 207.69KB
CYP Block Trade Proceeds to Reduce Director Loans
16/06/20PRICE SENSITIVE download Created with Sketch. 202.1KB
CYP Appendix 2A
10/06/20 download Created with Sketch. 165.93KB
CYP Investor Presentation
10/06/20 download Created with Sketch. 1.71MB
CYP Appendix 2A
02/06/20 download Created with Sketch. 166.6KB
CYP Cynata Successfully Completes Share Purchase Plan
27/05/20PRICE SENSITIVE download Created with Sketch. 174.02KB
CYP Ethics Approval to Commence Clinical Trial in COVID-19
08/05/20PRICE SENSITIVE download Created with Sketch. 210.99KB
CYP Cleansing Notice
01/05/20 download Created with Sketch. 124.37KB
CYP Appendix 2A
01/05/20 download Created with Sketch. 168.11KB
CYP Share Purchase Plan Booklet
30/04/20PRICE SENSITIVE download Created with Sketch. 169.42KB
CYP Cleansing Notice
24/04/20 download Created with Sketch. 123.75KB
CYP Appendix 2A
24/04/20 download Created with Sketch. 168.82KB
CYP Quarterly Activity Report & Appendix 4C
24/04/20PRICE SENSITIVE download Created with Sketch. 293.28KB
CYP Cynata announces $5.55m capital raising
22/04/20PRICE SENSITIVE download Created with Sketch. 212.56KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
15.5¢
Change
-0.015(8.82%)
Mkt cap ! $35.02M
Open High Low Value Volume
17.0¢ 17.0¢ 15.5¢ $35.01K 213.1K

Buyers (Bids)

No. Vol. Price($)
4 201289 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 14675 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
15.5¢
  Change
-0.015 ( 8.82 %)
Open High Low Volume
17.3¢ 17.3¢ 15.5¢ 186445
Last updated 15.55pm 31/07/2025 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.